ADVM Financial Statements

Balance sheet, income statement, cash flow, and dividends for Adverum Biotechnologies Inc (ADVM).


$97.15M Market Cap.

As of 04/15/2025 5:00 PM ET (MRY) • Disclaimer

ADVM Market Cap. (MRY)


ADVM Shares Outstanding (MRY)


ADVM Assets (MRY)


Total Assets

$179.84M

Total Liabilities

$109.13M

Total Investments

$65.04M

ADVM Income (MRY)


Revenue

$1.00M

Net Income

-$130.93M

Operating Expense

$140.16M

ADVM Cash Flow (MRY)


CF Operations

-$92.46M

CF Investing

-$41.89M

CF Financing

$120.00M

ADVM Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ADVM Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$179,841,000 (3.95%)

$173,010,000 (-43.90%)

$308,372,000 (-29.87%)

$439,727,000 (-8.88%)

Assets Current

$131,300,000 (27.76%)

$102,773,000 (-46.08%)

$190,595,000 (-39.90%)

$317,145,000 (-27.00%)

Assets Non-Current

$48,541,000 (-30.89%)

$70,237,000 (-40.36%)

$117,777,000 (-3.92%)

$122,582,000 (154.69%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$70,714,000 (-15.28%)

$83,469,000 (-54.02%)

$181,518,000 (-42.59%)

$316,185,000 (-27.20%)

Property Plant & Equipment Net

$45,218,000 (-32.54%)

$67,030,000 (-41.13%)

$113,861,000 (-4.37%)

$119,060,000 (152.78%)

Cash & Equivalents

$62,628,000 (-18.64%)

$76,976,000 (8.52%)

$70,934,000 (93.29%)

$36,698,000 (-42.14%)

Accumulated Other Comprehensive Income

-$407,000 (13.95%)

-$473,000 (69.11%)

-$1,531,000 (-114.43%)

-$714,000 (-173.56%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$65,039,000 (202.14%)

$21,526,000 (-81.63%)

$117,158,000 (-56.77%)

$270,993,000 (-26.22%)

Investments Current

$65,039,000 (202.14%)

$21,526,000 (-81.63%)

$117,158,000 (-56.77%)

$270,993,000 (-26.22%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$6,478,000 (0%)

Trade & Non-Trade Payables

$1,610,000 (-16.19%)

$1,921,000 (-14.16%)

$2,238,000 (61.36%)

$1,387,000 (-50.64%)

Accumulated Retained Earnings (Deficit)

-$1,066,951,000 (-16.00%)

-$919,777,000 (-14.60%)

-$802,612,000 (-23.85%)

-$648,076,000 (-28.96%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$86,037,000 (33.13%)

$64,627,000 (-30.93%)

$93,561,000 (-7.46%)

$101,108,000 (285.39%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$86,037,000 (33.13%)

$64,627,000 (-30.93%)

$93,561,000 (-7.46%)

$101,108,000 (285.39%)

Total Liabilities

$109,127,000 (21.87%)

$89,541,000 (-29.41%)

$126,854,000 (2.68%)

$123,542,000 (156.20%)

Liabilities Current

$22,898,000 (-8.09%)

$24,914,000 (-22.74%)

$32,246,000 (51.25%)

$21,320,000 (2.15%)

Liabilities Non-Current

$86,229,000 (33.43%)

$64,627,000 (-31.69%)

$94,608,000 (-7.45%)

$102,222,000 (273.77%)

ADVM Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,000,000 (-72.22%)

$3,600,000 (0%)

$0 (0%)

$7,500,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$63,118,000 (26.45%)

$49,915,000 (-13.73%)

$57,858,000 (-10.22%)

$64,441,000 (44.35%)

Research & Development Expense

$77,041,000 (-0.82%)

$77,676,000 (-21.76%)

$99,277,000 (11.32%)

$89,181,000 (21.65%)

Operating Expenses

$140,159,000 (9.85%)

$127,591,000 (-18.80%)

$157,135,000 (2.29%)

$153,622,000 (30.24%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

-$1,078,000 (-1556.76%)

$74,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$130,927,000 (-11.75%)

-$117,165,000 (24.18%)

-$154,536,000 (-6.18%)

-$145,540,000 (-23.86%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$130,927,000 (-11.75%)

-$117,165,000 (24.18%)

-$154,536,000 (-6.18%)

-$145,540,000 (-23.86%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$130,927,000 (-11.75%)

-$117,165,000 (24.18%)

-$154,536,000 (-6.18%)

-$145,540,000 (-23.86%)

Weighted Average Shares

$19,782,000 (-80.38%)

$100,824,000 (1.58%)

$99,251,000 (1.24%)

$98,039,000 (15.14%)

Weighted Average Shares Diluted

$19,782,000 (-80.38%)

$100,824,000 (1.58%)

$99,251,000 (1.24%)

$98,039,000 (15.14%)

Earning Before Interest & Taxes (EBIT)

-$130,927,000 (-10.73%)

-$118,243,000 (23.45%)

-$154,462,000 (-6.13%)

-$145,540,000 (-25.04%)

Gross Profit

$1,000,000 (-72.22%)

$3,600,000 (0%)

$0 (0%)

$7,500,000 (0%)

Operating Income

-$139,159,000 (-12.23%)

-$123,991,000 (21.09%)

-$157,135,000 (-7.54%)

-$146,122,000 (-23.88%)

ADVM Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$41,889,000 (-143.24%)

$96,875,000 (-31.64%)

$141,720,000 (80.06%)

$78,709,000 (128.09%)

Net Cash Flow from Financing

$120,003,000 (173817.39%)

$69,000 (-88.63%)

$607,000 (-74.68%)

$2,397,000 (-99.33%)

Net Cash Flow from Operations

-$92,462,000 (-1.72%)

-$90,902,000 (15.90%)

-$108,091,000 (-0.24%)

-$107,831,000 (-35.99%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$14,348,000 (-337.47%)

$6,042,000 (-82.35%)

$34,236,000 (228.10%)

-$26,725,000 (-669.51%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$41,501,000 (-142.49%)

$97,683,000 (-36.38%)

$153,536,000 (63.63%)

$93,832,000 (134.97%)

Capital Expenditure

-$388,000 (51.98%)

-$808,000 (93.16%)

-$11,816,000 (21.87%)

-$15,123,000 (-27.68%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$240,000 (-293.44%)

Issuance (Purchase) of Equity Shares

$120,003,000 (24440.49%)

$489,000 (-19.44%)

$607,000 (-76.98%)

$2,637,000 (-99.26%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$14,350,000 (-18.32%)

$17,569,000 (-12.50%)

$20,079,000 (-20.30%)

$25,194,000 (23.55%)

Depreciation Amortization & Accretion

$25,148,000 (34.69%)

$18,671,000 (186.01%)

$6,528,000 (40.54%)

$4,645,000 (11.71%)

ADVM Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00%

-

100.00%

Profit Margin

-13092.70% (-302.28%)

-3254.60%

-

-1940.50%

EBITDA Margin

-10577.90% (-282.44%)

-2765.90%

-

-1878.60%

Return on Average Equity (ROAE)

-92.70% (5.98%)

-98.60% (-46.29%)

-67.40% (-68.50%)

-40.00% (-26.58%)

Return on Average Assets (ROAA)

-56.00% (-6.06%)

-52.80% (-21.66%)

-43.40% (-42.76%)

-30.40% (-8.19%)

Return on Sales (ROS)

-13092.70% (-298.62%)

-3284.50%

-

-1940.50%

Return on Invested Capital (ROIC)

-77.10% (-4.33%)

-73.90% (-61.71%)

-45.70% (-58.68%)

-28.80% (12.99%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.7 (-8.63%)

-0.65 (-74.93%)

-0.37 (68.80%)

-1.19 (84.86%)

Price to Sales Ratio (P/S)

92.38 (338.18%)

21.08

-

23.01

Price to Book Ratio (P/B)

1.37 (50.82%)

0.91 (186.48%)

0.32 (-41.76%)

0.55 (-77.56%)

Debt to Equity Ratio (D/E)

1.54 (43.80%)

1.07 (53.51%)

0.7 (78.77%)

0.39 (252.25%)

Earnings Per Share (EPS)

-6.62 (-470.69%)

-1.16 (25.64%)

-1.56 (-5.41%)

-1.48 (-7.25%)

Sales Per Share (SPS)

0.05 (41.67%)

0.04 (0%)

0 (0%)

0.08 (0%)

Free Cash Flow Per Share (FCFPS)

-4.69 (-415.82%)

-0.91 (24.67%)

-1.21 (3.67%)

-1.25 (-17.20%)

Book Value Per Share (BVPS)

3.58 (331.76%)

0.83 (-54.73%)

1.83 (-43.29%)

3.23 (-36.78%)

Tangible Assets Book Value Per Share (TABVPS)

9.09 (429.78%)

1.72 (-44.77%)

3.11 (-30.72%)

4.49 (-20.87%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-2 (77.78%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.61 (-83.83%)

-0.33 (24.43%)

-0.44 (75.35%)

-1.79 (80.07%)

Asset Turnover

0 (-75.00%)

0.02 (0%)

0 (0%)

0.02 (0%)

Current Ratio

5.73 (39.01%)

4.13 (-30.21%)

5.91 (-60.26%)

14.88 (-28.54%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$92,850,000 (-1.24%)

-$91,710,000 (23.52%)

-$119,907,000 (2.48%)

-$122,954,000 (-34.91%)

Enterprise Value (EV)

$64,922,502 (95.33%)

$33,237,257 (-49.12%)

$65,323,970 (-74.14%)

$252,633,678 (-74.98%)

Earnings Before Tax (EBT)

-$130,927,000 (-10.73%)

-$118,243,000 (23.45%)

-$154,462,000 (-6.13%)

-$145,540,000 (-25.04%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$105,779,000 (-6.23%)

-$99,572,000 (32.69%)

-$147,934,000 (-5.00%)

-$140,895,000 (-25.54%)

Invested Capital

$180,352,000 (32.86%)

$135,747,000 (-54.56%)

$298,753,000 (-38.12%)

$482,817,000 (13.74%)

Working Capital

$108,402,000 (39.23%)

$77,859,000 (-50.83%)

$158,349,000 (-46.47%)

$295,825,000 (-28.47%)

Tangible Asset Value

$179,841,000 (3.95%)

$173,010,000 (-43.90%)

$308,372,000 (-29.87%)

$439,727,000 (-8.88%)

Market Capitalization

$97,147,502 (27.74%)

$76,053,257 (31.60%)

$57,792,970 (-66.54%)

$172,747,678 (-83.65%)

Average Equity

$141,286,750 (18.95%)

$118,773,750 (-48.19%)

$229,232,250 (-37.03%)

$364,036,750 (-1.98%)

Average Assets

$233,961,750 (5.53%)

$221,696,500 (-37.69%)

$355,770,750 (-25.80%)

$479,501,500 (14.85%)

Invested Capital Average

$169,722,250 (6.06%)

$160,018,250 (-52.63%)

$337,840,000 (-33.22%)

$505,868,750 (43.88%)

Shares

20,802,463 (-79.41%)

101,027,174 (1.30%)

99,729,025 (1.61%)

98,152,090 (0.69%)